文献速递关节外科

急性假体周围关节感染行清创、抗生素及假体保留术:126例初次髋关节置换术七年延长随访结果

Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection: Results of 126 Primary Hip Arthroplasties at Extended Follow-Up of Seven Years.
PubMed 文献 · J Arthroplasty · 2025-03-23

单中心回顾126例初次髋关节置换术后急性假体周围关节感染,均行单次清创、抗生素及假体保留术(DAIR)并慢性抗生素抑制,平均随访七年;无再感染生存率五年为77%,McPherson宿主分级C级可预测再感染(HR 5,P=0.03)。

要点

  • 急性假体周围关节感染单次DAIR后无再感染生存率五年为77%。
  • 早期术后与急性血源性假体周围关节感染的无再感染生存率无差异(P=0.1)。
  • McPherson宿主分级C级可预测再感染(HR 5,P=0.03)。

核心结论

  • 在126例初次髋关节置换术后急性假体周围关节感染行单次DAIR的大系列中,五年无感染生存率为77%。
  • 宿主状态差可预测再感染。
  • 采用严格的急性假体周围关节感染定义时,延长随访的成功率较许多历史系列明显提高。

研究设计与样本

  • 单中心回顾性识别2000年至2021年间126髋(108例全髋关节置换术、18例半髋置换术)急性假体周围关节感染,均行DAIR后慢性抗生素抑制。
  • 急性术后假体周围关节感染定义为初次髋关节置换术后四周内发生的感染;急性血源性假体周围关节感染定义为初次髋关节置换术后超过四周发生且症状持续少于21天的感染。
  • 平均年龄67岁,44%为女性,平均体重指数34,平均随访七年,采用Kaplan-Meier生存分析。

主要发现

  • 无再感染生存率一年为80%、两年为79%、五年为77%。
  • 早期术后与急性血源性假体周围关节感染的无再感染生存率无差异(P=0.1)。
  • McPherson宿主分级C级可预测再感染(风险比5,P=0.03)。
  • 33%的再感染由原微生物引起,再感染中位时间13天。
  • 无任何翻修生存率五年为82%;翻修指征包括复发性假体周围关节感染(91%)、脱位(5%)和无菌性失败(5%)。

关键数值与推荐

  • 急性术后假体周围关节感染定义为初次髋关节置换术后四周内感染。
  • 急性血源性假体周围关节感染定义为初次髋关节置换术后超过四周发生且症状持续少于21天。
  • McPherson宿主分级C级预测再感染的风险比5(P=0.03)。
  • 无再感染生存率一年80%、两年79%、五年77%;无任何翻修生存率五年82%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is renewed interest in debridement, antibiotics, and implant retention (DAIR) for acute periprosthetic joint infections (PJIs). The purpose of this study was to assess the results of single DAIRs for acute PJI after primary hip arthroplasty in a large series with extended follow-up. METHODS: We identified 126 hips (108 total hip arthroplasties, 18 hemiarthroplasties) with acute PJIs treated with DAIR followed by chronic antibiotic suppression between 2000 and 2021 at a single institution. Acute postoperative PJI was defined as infection within four weeks of primary hip arthroplasty, and acute hematogenous PJI was defined as infection occurring more than four weeks after primary hip arthroplasty with symptoms for less than 21 days. The mean age was 67 years, 44% were women, and the mean body mass index was 34. Kaplan-Meier survivorship analyses were performed. The mean follow-up was seven years. RESULTS: Survivorship free of reinfection was 80% at one year, 79% at two years, and 77% at five years. There was no difference in survivorship free of reinfection between early postoperative and acute hematogenous PJIs (P = 0.1). McPherson Host Grade C was predictive of reinfection (hazard ratio 5, P = 0.03). Reinfection was caused by the original organism in 33% of hips. The median time to reinfection was 13 days. Survivorship free of any revision was 82% at five years. Indications for revision included recurrent PJI (91%), dislocation (5%), and aseptic failures (5%). CONCLUSIONS: In this large series of acute PJIs after primary hip arthroplasties treated with a single DAIR, infection-free survival was 77% at five years. Poor host status predicted reinfection. With a rigorous definition of acute PJI, success was markedly improved at extended follow-up compared to many historical series.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Terhune EB, Elmenawi KA, Grimm JA, et al. Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection: Results of 126 Primary Hip Arthroplasties at Extended Follow-Up of Seven Years. J Arthroplasty. 2025. PMID: 40128137. doi:10.1016/j.arth.2025.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。